Catalent has agreed to acquire Bettera Brands’ parent company, Bettera Holdings, from Highlander Partners for $1 billion.
Headquartered in Plano, Texas, Bettera Brands is a nutritional supplements company which manufactures gummy vitamins, soft chews and lozenges.
Highlander formed Bettera – which has four manufacturing facilities across the US – through a series of four acquisitions beginning in 2017.
Drug manufacturer Catalent expects its acquisition of Bettera to accelerate the growth of its softgel and oral dose formulation and manufacturing business.
The deal will also enable Catalent to expand its consumer health technology platform with new technologies and ready-to-market product libraries, as well as a variety of packaging options.
“As the leading global innovator of softgel and oral technologies, Catalent has a strong, long-standing presence in the rapidly expanding consumer health and nutraceutical marketplace,” said Aris Gennadios, president, softgel and oral technologies, Catalent.
“This acquisition allows us to significantly accelerate the growth of our consumer health business and offer customers access to the substantial potential in gummies, soft chews and lozenges, which are all experiencing double-digit growth.”
Jeff Hull, president and CEO of Highlander Partners, added: “Bettera was established with a vision to serve the needs of consumers who want to experience the benefits of nutritional supplements through more enjoyable and convenient dose forms.
“Catalent has long had a similar vision, combined with specialised expertise, a history of successful innovation, a wide range of offerings, and the resources to help Bettera continue to grow and meet customer and consumer needs.
“Together, Catalent Consumer Health and Bettera are well positioned to continue Bettera’s mission of serving consumers and participating in the long-term growth of the self-care market.”
The transaction is expected to close by the end of the year and is subject to customary closing conditions.
© FoodBev Media Ltd 2024
